Global Veterinary Intravenous IV Solutions Market Report 2025

Veterinary Intravenous (IV) Solutions Global Market Report 2025 – By Product (Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition), By Animal Type (Companion Animals, Production Animals), By End-User (Veterinary Hospitals And Clinics, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Veterinary Intravenous (IV) Solutions Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Veterinary Intravenous (IV) Solutions Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Veterinary Intravenous (IV) Solutions Market Definition

Veterinary intravenous (IV) solutions are sterile fluids administered directly into the bloodstream of animals through a vein, typically via an IV catheter. These solutions are used in veterinary medicine to treat dehydration and electrolyte imbalances, deliver medications, or provide nutrients. Veterinary intravenous (IV) solutions are essential for maintaining or restoring the proper fluid and electrolyte balance in animals, especially in illness, surgery, or trauma cases.

The main product types of veterinary intravenous (iv) solutions are isotonic crystalloids, dextrose solutions, synthetic colloids, natural colloids, and parenteral nutrition. Isotonic crystalloids are intravenous (IV) fluids that have the same concentration of solutes as the blood, helping to maintain fluid balance in the body. The various animal types include companion animals and production animals. These are used by various end-users such as veterinary hospitals and clinics, research institutes, and others.

Veterinary Intravenous (IV) Solutions Market Segmentation

The veterinary intravenous (IV) solutions market covered in this report is segmented –

1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition

2) By Animal Type: Companion Animals, Production Animals

3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer's Solution, Dextrose in Water (D5W), Ringer's Solution, Balanced Electrolyte Solutions

2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)

3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins

4) Natural Colloids: albumin, Fresh Frozen Plasma (FFP), Blood Products

5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions

Veterinary Intravenous (IV) Solutions Market Size and growth rate 2025 to 2029: Graph

Veterinary Intravenous (IV) Solutions Market Size 2025 And Growth Rate

The veterinary intravenous (IV) solutions market size has grown strongly in recent years. It will grow from $1.5 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing number of veterinary clinics, rise in incidence of dehydration, growth in livestock farming, rise in the number of companion animals, and growth in veterinary diagnostics.

Veterinary Intravenous (IV) Solutions Market Growth Forecast

The veterinary intravenous (IV) solutions market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising adoption of pet insurance, increasing animal healthcare expenditure, growing awareness of animal healthcare, rising incidence of animal diseases, and increasing pet insurance coverage. Major trends in the forecast period include technological advancements, diverse product formulations, telemedicine integration, advanced veterinary intravenous (IV) delivery systems, and smart veterinary intravenous (IV) systems.

Veterinary Intravenous (IV) Solutions Market Driver: Rising Prevalence Of Animal Diseases Fuels Market Growth

The increase in the prevalence of various animal diseases is expected to propel the growth of the veterinary intravenous (IV) solutions market going forward. Animal diseases refer to conditions or disorders that impair the health and function of animals. The common animal diseases are anthrax, leptospirosis, rabies, canine distemper, heartworm disease, and more. The increase in the prevalence of various animal diseases is driven by several factors, including intensive farming practices, wildlife encroachment, and antibiotic resistance. Veterinary intravenous solutions are essential for rehydrating animals affected by dehydration-inducing diseases, such as gastroenteritis or severe infections, by ensuring optimal hydration and supporting overall health outcomes. For instance, in July 2024, according to AVMA Publications, a US-based publishing division of the American Veterinary Medical Association, around 345 domestic animals were confirmed to have rabies in 2022, marking a 10.9% increase compared to the 311 cases reported in 2021. Therefore, the increase in the prevalence of various animal diseases is driving the growth of the veterinary intravenous (IV) solutions market.

Veterinary Intravenous (IV) Solutions Driver: Rising Expenditure On Animal Health Products Drives Veterinary IV Solutions Market

The increasing spending on animal health products is expected to propel the growth of the veterinary intravenous (IV) solutions market going forward. Animal health products refer to medications, supplements, and treatments used to maintain or improve the health and well-being of animals. The increasing spending on animal health products is driven by factors such as rising pet ownership, growing awareness of animal health, advancements in veterinary care, and the need for better disease prevention and treatment options. Veterinarian IV solutions help to increase spending on animal health products by meeting urgent medical demands and advancing veterinary care. For instance, in March 2024, according to the Republic of Estonia Agency of Medicines, an Estonia-based regulatory authority, in 2023, the veterinary medicinal products market increased by 6.9%, reaching $20.54 million (18.6 million euros) up from USD 19.21 million (17.40 million euros) in 2022. Therefore, the increasing spending on animal health products is driving the growth of the veterinary intravenous (IV) solutions market.

Global Veterinary Intravenous (IV) Solutions Market Major Players

Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd

Global Veterinary Intravenous (IV) Solutions Market Trend: Advancements In Veterinary IV Solutions For Respiratory Infections

Major companies operating in the veterinary intravenous (IV) solutions market are focusing on developing advanced products such as fluoroquinolone to help improve efficacy and safety profiles. Fluoroquinolones are a powerful class of antibiotics used in human and veterinary medicine to treat various bacterial infections that can be managed carefully to minimize the risk of resistance and side effects. For instance, in April 2024, Elanco, a US-based pharmaceutical company, announced Pradalex, a pradofloxacin injection solution approved by the US Food and Drug Administration (FDA), a US-based health organization. The approval for swine is for the treatment of swine respiratory disease (SRD) associated with bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Pradalex is a 3rd generation fluoroquinolone, ranked as a critically important antimicrobial. The drug's label includes a statement that it should be used only after considering other non-fluoroquinolone therapeutic options.

Regional Outlook For The Global Veterinary Intravenous (IV) Solutions Market

North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary intravenous (IV) solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Veterinary Intravenous (IV) Solutions Market?

The veterinary intravenous (IV) solutions market consists of sales of hypertonic solutions, isotonic solutions, and hypertonic solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Veterinary Intravenous (IV) Solutions Industry?

The veterinary intravenous (IV)solutions market research report is one of a series of new reports from The Business Research Company that provides veterinary intravenous (IV) solutions market statistics, including veterinary intravenous (IV) solutions industry global market size, regional shares, competitors with a veterinary intravenous (IV) solutions market share, detailed veterinary intravenous (IV) solutions market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary intravenous (IV) solutions industry. This veterinary intravenous (IV) solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary Intravenous IV Solutions Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 1.62 billion
Revenue Forecast In 2034 $2.19 billion
Growth Rate CAGR of 7.8% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The veterinary intravenous (IV) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer's Solution, Dextrose in Water (D5W), Ringer's Solution, Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Veterinary Intravenous (IV) Solutions Market Characteristics

    3. Veterinary Intravenous (IV) Solutions Market Trends And Strategies

    4. Veterinary Intravenous (IV) Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Veterinary Intravenous (IV) Solutions Growth Analysis And Strategic Analysis Framework

    5.1. Global Veterinary Intravenous (IV) Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Veterinary Intravenous (IV) Solutions Market Growth Rate Analysis

    5.4. Global Veterinary Intravenous (IV) Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Veterinary Intravenous (IV) Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Veterinary Intravenous (IV) Solutions Total Addressable Market (TAM)

    6. Veterinary Intravenous (IV) Solutions Market Segmentation

    6.1. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Isotonic Crystalloids

    Dextrose Solutions

    Synthetic Colloids

    Natural Colloids

    Parenteral Nutrition

    6.2. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Companion Animals

    Production Animals

    6.3. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Veterinary Hospitals And Clinics

    Research Institutes

    Other End-Users

    6.4. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Normal Saline (0.9% NaCl)

    Lactated Ringer's Solution

    Dextrose in Water (D5W)

    Ringer's Solution

    Balanced Electrolyte Solutions

    6.5. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Dextrose 5% in Water (D5W)

    Dextrose 10% in Water (D10W)

    Dextrose 20% in Water (D20W)

    Dextrose 50% in Water (D50W)

    6.6. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hydroxyethyl Starch (HES)

    Dextran

    Gelatins

    6.7. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Albumin

    Fresh Frozen Plasma (FFP)

    Blood Products

    6.8. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Total Parenteral Nutrition (TPN) Solutions

    Partial Parenteral Nutrition Solutions

    Lipid Emulsions

    Amino Acid Solutions

    7. Veterinary Intravenous (IV) Solutions Market Regional And Country Analysis

    7.1. Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Veterinary Intravenous (IV) Solutions Market

    8.1. Asia-Pacific Veterinary Intravenous (IV) Solutions Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Veterinary Intravenous (IV) Solutions Market

    9.1. China Veterinary Intravenous (IV) Solutions Market Overview

    9.2. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Veterinary Intravenous (IV) Solutions Market

    10.1. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Veterinary Intravenous (IV) Solutions Market

    11.1. Japan Veterinary Intravenous (IV) Solutions Market Overview

    11.2. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Veterinary Intravenous (IV) Solutions Market

    12.1. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Veterinary Intravenous (IV) Solutions Market

    13.1. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Veterinary Intravenous (IV) Solutions Market

    14.1. South Korea Veterinary Intravenous (IV) Solutions Market Overview

    14.2. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Veterinary Intravenous (IV) Solutions Market

    15.1. Western Europe Veterinary Intravenous (IV) Solutions Market Overview

    15.2. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Veterinary Intravenous (IV) Solutions Market

    16.1. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Veterinary Intravenous (IV) Solutions Market

    17.1. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Veterinary Intravenous (IV) Solutions Market

    18.1. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Veterinary Intravenous (IV) Solutions Market

    19.1. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Veterinary Intravenous (IV) Solutions Market

    20.1. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Veterinary Intravenous (IV) Solutions Market

    21.1. Eastern Europe Veterinary Intravenous (IV) Solutions Market Overview

    21.2. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Veterinary Intravenous (IV) Solutions Market

    22.1. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Veterinary Intravenous (IV) Solutions Market

    23.1. North America Veterinary Intravenous (IV) Solutions Market Overview

    23.2. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Veterinary Intravenous (IV) Solutions Market

    24.1. USA Veterinary Intravenous (IV) Solutions Market Overview

    24.2. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Veterinary Intravenous (IV) Solutions Market

    25.1. Canada Veterinary Intravenous (IV) Solutions Market Overview

    25.2. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Veterinary Intravenous (IV) Solutions Market

    26.1. South America Veterinary Intravenous (IV) Solutions Market Overview

    26.2. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Veterinary Intravenous (IV) Solutions Market

    27.1. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Veterinary Intravenous (IV) Solutions Market

    28.1. Middle East Veterinary Intravenous (IV) Solutions Market Overview

    28.2. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Veterinary Intravenous (IV) Solutions Market

    29.1. Africa Veterinary Intravenous (IV) Solutions Market Overview

    29.2. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type

    , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Veterinary Intravenous (IV) Solutions Market Competitive Landscape And Company Profiles

    30.1. Veterinary Intravenous (IV) Solutions Market Competitive Landscape

    30.2. Veterinary Intravenous (IV) Solutions Market Company Profiles

    30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

    31. Veterinary Intravenous (IV) Solutions Market Other Major And Innovative Companies

    31.1. B. Braun Melsungen AG

    31.2. Virbac SA

    31.3. Dechra Pharmaceuticals PLC

    31.4. Vetoquinol SA

    31.5. Norbrook Laboratories Limited

    31.6. Ceva Santé Animale

    31.7. Revival Animal Health Inc.

    31.8. Aromor Animal Health

    31.9. Jorgensen Laboratories LLC

    31.10. Pharmacosmos AS

    31.11. Sykes Veterinary International Pty Ltd.

    31.12. Rusoma Laboratories Private Limited

    31.13. Patterson Companies Inc.

    31.14. NexGen Veterinary

    31.15. Soxa Formulations & Research Pvt.Ltd

    32. Global Veterinary Intravenous (IV) Solutions Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Veterinary Intravenous (IV) Solutions Market

    34. Recent Developments In The Veterinary Intravenous (IV) Solutions Market

    35. Veterinary Intravenous (IV) Solutions Market High Potential Countries, Segments and Strategies

    35.1 Veterinary Intravenous (IV) Solutions Market In 2029 - Countries Offering Most New Opportunities

    35.2 Veterinary Intravenous (IV) Solutions Market In 2029 - Segments Offering Most New Opportunities

    35.3 Veterinary Intravenous (IV) Solutions Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: Baxter International Inc. Financial Performance
  • Table 81: Zoetis Inc. Financial Performance
  • Table 82: Fresenius Kabi AG Financial Performance
  • Table 83: Elanco Animal Health Incorporated Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
  • , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: Baxter International Inc. Financial Performance
  • Figure 81: Zoetis Inc. Financial Performance
  • Figure 82: Fresenius Kabi AG Financial Performance
  • Figure 83: Elanco Animal Health Incorporated Financial Performance
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Veterinary Intravenous (IV) Solutions market?

Veterinary intravenous (IV) solutions are sterile fluids administered directly into the bloodstream of animals through a vein, typically via an IV catheter. These solutions are used in veterinary medicine to treat dehydration and electrolyte imbalances, deliver medications, or provide nutrients. Veterinary intravenous (IV) solutions are essential for maintaining or restoring the proper fluid and electrolyte balance in animals, especially in illness, surgery, or trauma cases. For further insights on the Veterinary Intravenous (IV) Solutions market, request a sample here

How will the Veterinary Intravenous (IV) Solutions market drivers and restraints affect the market dynamics? What forces will shape the Veterinary Intravenous (IV) Solutions industry going forward?

The Veterinary Intravenous (IV) Solutions market major growth driver - Rising Prevalence Of Animal Diseases Fuels Market Growth. For further insights on the Veterinary Intravenous (IV) Solutions market, request a sample here

What is the forecast market size or the forecast market value of the Veterinary Intravenous (IV) Solutions market?

The Veterinary Intravenous (IV) Solutions market size has grown strongly in recent years. The veterinary intravenous (IV) solutions market size has grown strongly in recent years. It will grow from $1.5 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing number of veterinary clinics, rise in incidence of dehydration, growth in livestock farming, rise in the number of companion animals, and growth in veterinary diagnostics. The veterinary intravenous (IV) solutions market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising adoption of pet insurance, increasing animal healthcare expenditure, growing awareness of animal healthcare, rising incidence of animal diseases, and increasing pet insurance coverage. Major trends in the forecast period include technological advancements, diverse product formulations, telemedicine integration, advanced veterinary intravenous (IV) delivery systems, and smart veterinary intravenous (IV) systems. For further insights on the Veterinary Intravenous (IV) Solutions market, request a sample here

How is the Veterinary Intravenous (IV) Solutions market segmented?

The veterinary intravenous (IV) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer's Solution, Dextrose in Water (D5W), Ringer's Solution, Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions For further insights on the Veterinary Intravenous (IV) Solutions market,
request a sample here

Which region has the largest share of the Veterinary Intravenous (IV) Solutions market? What are the other regions covered in the report?

North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Veterinary Intravenous (IV) Solutions market, request a sample here.

Who are the major players in the Veterinary Intravenous (IV) Solutions market?

Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd . For further insights on the Veterinary Intravenous (IV) Solutions market, request a sample here.

What are the key trends in the Veterinary Intravenous (IV) Solutions market?

Major trends in the Veterinary Intravenous (IV) Solutions market include Advancements In Veterinary IV Solutions For Respiratory Infections. For further insights on the Veterinary Intravenous (IV) Solutions market, request a sample here.

What are the major opportunities in the Veterinary Intravenous (IV) Solutions market? What are the strategies for the Veterinary Intravenous (IV) Solutions market?

For detailed insights on the major opportunities and strategies in the Veterinary Intravenous (IV) Solutions market, request a sample here.

How does the Veterinary Intravenous (IV) Solutions market relate to the overall economy and other similar markets?

For detailed insights on Veterinary Intravenous (IV) Solutions's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Veterinary Intravenous (IV) Solutions industry?

For detailed insights on the mergers and acquisitions in the Veterinary Intravenous (IV) Solutions industry, request a sample here.

What are the key dynamics influencing the Veterinary Intravenous (IV) Solutions market growth? SWOT analysis of the Veterinary Intravenous (IV) Solutions market.

For detailed insights on the key dynamics influencing the Veterinary Intravenous (IV) Solutions market growth and SWOT analysis of the Veterinary Intravenous (IV) Solutions industry, request a sample here.